Tracer Gas Physicochemical Properties Influence DLCO Measurements in Patients With Ventilation Heterogeneity

Area of Science:

• Pulmonary Physiology
• Respiratory Medicine
• Diagnostic Tools

Background:

• Lung diffusing capacity for carbon monoxide (DLCO) measurement relies on inert tracer gases to determine alveolar volume (VA).
• Commonly used helium (He) has different properties than alternatives like argon (Ar), sulfur hexafluoride (SF₆), and methane (CH₄), potentially affecting DLCO results.

Purpose of the Study:

• To evaluate the impact of different inert tracer gases on DLCO and VA measurements across various respiratory conditions.
• To assess the influence of tracer gas diffusivity and molecular weight on physiological measurements.

Main Methods:

• A pilot study involving 27 subjects (healthy, airflow obstruction, emphysema, CPFE/ILD) was conducted.
• A multigas DLCO mixture was analyzed using a Cosmed Quark PFT 4 system with mass spectrometry.
• Gas concentrations were measured at 25%, 50%, and 75% of expiration to assess ventilation distribution.

Main Results:

• Tracer gas diffusivity significantly influenced VA estimation and DLCO in patients with lung diseases, with differences up to +26.7% observed in the emphysema group (SF₆ vs. He).
• Healthy subjects showed no significant impact from varying tracer gases on DLCO measurements.
• Later expiratory sampling showed potential to reduce variability in diseased lungs.

Conclusions:

• The choice of tracer gas impacts DLCO measurements in patients with various lung diseases, necessitating careful consideration.
• Standardizing tracer gas use is crucial for enhancing inter-laboratory comparability of DLCO results.
• Further validation is needed for strategies like later expiratory sampling to reduce measurement variability.